Genprex, Inc. Made Big Gain

Mon, Jan 03, 2022 at 05:32 PM

Genprex, Inc. (GNPX:NASDAQ) jumped higher at $3.5, a gain of 167.2%. The stock got featured on our News Catalysts scanner on Mon, Jan 03, 2022 at 05:02 PM in the 'BIOTECH' category. From Thu, Dec 16, 2021, the stock recorded 44.44% Up Days and 40.00% Green Days

About Genprex, Inc. (GNPX:NASDAQ)

Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.

Top 10 Gainers:

CCTS (CCTS:NASDAQ), 2897.07%
Genprex, Inc. (GNPX:NASDAQ), 167.18%
DPCS (DPCS:NASDAQ), 100%
GVCI (GVCI:NASDAQ), 100%
LGVC (LGVC:NASDAQ), 100%
IMMX (IMMX:NASDAQ), 62.36%
Armstrong Flooring, Inc. (AFI:NYSE), 39.9%
WAVE (WAVE:NASDAQ), 39.86%
IMPP (IMPP:NASDAQ), 34.02%
MIMO (MIMO:NYSEMKT), 27.44%